ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,158.62
0.60%
US Tech 100
17,529.00
0.63%
다우존스 지수
38,730.73
0.14%
Bitcoin
63,652.59
-0.54%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Acadia Pharmaceuticals Inc (ACAD)

  7. Acadia Pharmaceuticals Inc (ACAD) 뉴스

ACAD

Acadia Pharmaceuticals (ACAD)

Acadia Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ACAD
일자시간출처헤드라인심볼기업
2024/04/3005:16Business WireAcadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling ScholarshipNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/04/2505:05Business WireAcadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024NASDAQ:ACADAcadia Pharmaceuticals Inc
2024/04/2222:04Business WireAcadia Pharmaceuticals annonce que la présentation de drogue nouvelle pour la trofinetide dans le traitement du syndrome de Rett a été acceptée pour dépôt et évaluation prioritaire par Santé CanadaNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/04/2222:04Business WireAcadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health CanadaNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/04/2005:05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
2024/04/1805:05Business WireAcadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual MeetingNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/04/0305:05Business WireAcadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and DevelopmentNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/04/0205:05Business WireAcadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/03/1605:05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
2024/03/1405:05Business WireAcadia Pharmaceuticals to Participate in the UBS Virtual CNS DayNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/03/1220:21IH Market NewsOracle Soars 13% With Exceptional Growth and Boosts Nvidia Shares With Collaboration Announcement, and MoreNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/03/1205:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/03/1205:05Business WireAcadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of SchizophreniaNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/2923:05Business WireAcadia Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference on March 6, 2024NASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/2808:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/2808:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/2808:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/2808:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/2806:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/2806:05Business WireAcadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating OverviewNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/2206:05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/1421:08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/1406:05Business WireAcadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024NASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/0907:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/02/0907:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/01/3111:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/01/3110:48Business WireAcadia Announces Additions to Executive TeamNASDAQ:ACADAcadia Pharmaceuticals Inc
2024/01/2707:25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACADAcadia Pharmaceuticals Inc
2024/01/2006:05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
2024/01/1906:05Business WireAcadia Announces the Passing of Former President Srdjan (Serge) StankovicNASDAQ:ACADAcadia Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:ACAD

최근 히스토리

USOTC
BASFY
BASF (QX)
CCOM
US100
US Tech 100
NYSE
CVX
Chevron
COIN
SOLUSD
Solana
NYSE
VZ
Verizon Communications
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
AXP
American Express
AMEX
SPY
SPDR S&P 500
NASDAQ
GOOGL
Alphabet
FX
USDJPY
US Dollar vs Yen
CCOM
SILVER
SILVER
USOTC
ADDYY
Adidas (QX)
NYSE
MRK
Merck
NYSE
KO
Coca Cola
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유